RA Capital Management, L.P., 10% Owner at Hemab Therapeutics Holdings, Inc. (COAG), bought 6,387 shares at $24.90 ($159K) on 2026-05-12, disclosed to the SEC on 2026-05-14.
Open-market purchase of $159k COAG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $58K | — | Filing → |